Early research (Phase 1)Study completedNCT00832117What this trial is testingPhase I Combination Ixabepilone + CisplatinWho this might be right forNon Small Cell Lung Cancer R-Pharm 30
Early research (Phase 1)Not Yet RecruitingNCT06218940What this trial is testingHY1272 in Patients With Locally Advanced or Metastatic Solid Tumors or Locally Advanced or Metastatic EGFRm+ NSCLCWho this might be right forNSCLC Stage IV Newsoara Biopharma Co., Ltd. 40
Early research (Phase 1)Study completedNCT04752215What this trial is testingA Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell SurfaceWho this might be right forColorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Carcinoma, Hepatocellular, Head and Neck Neoplasms, Gastrointestinal Neoplasms Boehringer Ingelheim 67
Early research (Phase 1)Looking for participantsNCT07623369What this trial is testingA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forSolid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Huahui Health 299
Early research (Phase 1)UnknownNCT00024063What this trial is testingSU006668 in Treating Patients With Advanced Solid TumorsWho this might be right forBreast CancerColorectal CancerGastric Cancer+5 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07151040What this trial is testingPhase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid TumorsWho this might be right forSolid TumorColorectal Cancer (CRC)Squamous Cell Carcinoma of Head and Neck+3 more One-carbon Therapeutics AB 43
Testing effectiveness (Phase 2)Ended earlyNCT03138889What this trial is testingBempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid TumorsWho this might be right forNon-Small Cell Lung Cancer Nektar Therapeutics 162
Testing effectiveness (Phase 2)Study completedNCT01100931What this trial is testingA Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)Who this might be right forNSCLCSolid Tumors National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT02711137What this trial is testingOpen-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesWho this might be right forSolid Tumors Incyte Corporation 137
Early research (Phase 1)Study completedNCT00514007What this trial is testingStudy of Continuous OSI-906 DosingWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 95
Testing effectiveness (Phase 2)Looking for participantsNCT04930432What this trial is testingStudy of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid TumorsWho this might be right forSolid TumorNon-Small Cell Lung CancerHead and Neck Cancer+1 more Betta Pharmaceuticals Co., Ltd. 400
Early research (Phase 1)Ended earlyNCT01110226What this trial is testingTrial Of Cisplatin And KML-001 in Platinum Responsive MalignanciesWho this might be right forNon-Small Cell Lung Cancer, Small Cell Lung CancerPlatinum Responsive Malignancies University of Maryland, Baltimore 23
Early research (Phase 1)Active Not RecruitingNCT06447662What this trial is testingLearn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.Who this might be right forCarcinoma, Pancreatic DuctalColorectal NeoplasmsCarcinoma, Non-Small-Cell Lung Pfizer 64
Testing effectiveness (Phase 2)Study completedNCT00264433What this trial is testingThe Safety and Effects of ADH-1 Given Intravenously as a Single AgentWho this might be right forNeoplasms Adherex Technologies, Inc.
Early research (Phase 1)Ended earlyNCT05317078What this trial is testingSafety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor IndicationsWho this might be right forNon-squamous Non-small Cell Lung CancerEpithelial Ovarian CancerClaudin 6-positive Advanced/Metastatic Malignant Solid Tumors Amgen 3
Testing effectiveness (Phase 2)UnknownNCT06519110What this trial is testingNeratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 MutationsWho this might be right forAdvanced Solid Tumor Convalife (Shanghai) Co., Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT06172478What this trial is testingHER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMelanomaHead and Neck Cancer+11 more Daiichi Sankyo 740
Early research (Phase 1)Ended earlyNCT02650635What this trial is testingTLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsWho this might be right forColorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Breast Carcinoma+14 more Mayo Clinic 4
Early research (Phase 1)Not Yet RecruitingNCT05698238What this trial is testingClinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid TumoursWho this might be right forClear Cell Renal Cell Carcinoma MetastaticTNBC - Triple-Negative Breast CancerHead and Neck Cancer+2 more Mabpro, a.s. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06281678What this trial is testingIBI363 in Subjects with Advanced Solid MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerColorectal Cancer+1 more Innovent Biologics (Suzhou) Co. Ltd. 178